Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Tuesday, June 20 • 4:00pm - 5:15pm
#289: Value and Access for Special Populations: From Access Restriction to Drug Mortgages

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

Therapies for rare diseases present particular challenges for access, distribution, and coverage. This session will provide insights into the steps required for patient access to approved and unapproved products as well as distribution and current legal framework challenges. Attendees will learn how to overcome barriers today for improved access tomorrow.

Learning Objectives

Identify challenges impacting drug availability in rare diseases; Define scope of legal and regulatory framework for market access.

Chair

Roxanne Tavakkol, MS

Speaker

Addressing Urgent Access to Therapeutic Treatment Needs: Meeting the Need for Urgent Access to Therapeutic Treatments
Roxanne Tavakkol, MS

Panelist
William A. Sarraille, JD

Gaining Access to Orphan/Special Drug Therapies
John J. Maddox, JR, MBA, RPh



Moderators
avatar for Roxanne Tavakkol

Roxanne Tavakkol

Vice President, Regulatory Affairs, Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals
Roxanne Tavakkol has held executive level positions in the biotechnology industry, as well as small and large pharma, during her 25 year career in Regulatory Affairs. A key focus of her efforts has been regulatory strategy, from proof of concept through successful product marketi... Read More →

Speakers
JM

John Maddox

Founder & Managing Director, Infusion Pharma Consulting LLC
John is Founder & Managing Director of Infusion, a strategy consultancy focused on the Orphan, Hospital & Specialty markets. Founded in 2003, Infusion serves clients worldwide. Its largest practice, Strategic Pricing & Market Access, has developed pricing for some of the most tec... Read More →
WS

William Sarraille

Partner, Sidley Austin, LLP
Bill Sarraille is a senior member of the Healthcare Practice group and a nationally-recognized lawyer in healthcare law.
avatar for Roxanne Tavakkol

Roxanne Tavakkol

Vice President, Regulatory Affairs, Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals
Roxanne Tavakkol has held executive level positions in the biotechnology industry, as well as small and large pharma, during her 25 year career in Regulatory Affairs. A key focus of her efforts has been regulatory strategy, from proof of concept through successful product marketi... Read More →


Tuesday June 20, 2017 4:00pm - 5:15pm
N426c McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616